MDM2 and p53 in childhood acute lymphoblastic leukemia: Higher expression in childhood leukemias with poor prognosis compared to long-term survivors

Pediatric Hematology and Oncology

Volumn 18, Issue 8, 2001, Pages 497-508

  Gustafsson, B ^a   Axelsson, B ^a   Christensson, B ^a   Winiarski, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Childhood leukemia; Immunohistochemistry; MDM2; p21; p53

Indexed keywords

PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; PROGNOSIS;

ADOLESCENT; BONE MARROW; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; SURVIVORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035192248     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800101753328466     Document Type: Article

References (25)

1. The INK4a/ARF tumor suppressor: One-gene-two products-two pathways
2. p53, guardian of the genome
3. kip1 cyclin-dependent kinase inhibitors during human hematopoesis
4. Mutations of the p53 gene in lymphoid leukemia
5. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia
6. Hereditary and acquired p53 gene mutations in childhood ALL
7. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
8. Exon 5 mutations in the p53 gene in relapsed childhood ALL
9. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T cell ALL
10. p53 gene status and chemosensitivity of childhood acute lymphoblastic leukaemia cells to adriamycin
11. MDM2 and p53: A question of balance
12. Regulation of p53 stability by Mdm2
13. Altered expression of p53 and mdm2 proteins at diagnosis is associated with early treatment failure in childhood acute lymhpoblastic leukemia
14. High incidence of potential p53 inactivation in poor outcome childhood ALL at diagnosis
15. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukaemia
16. Loss of function and p53 protein stabilization
17. Overexpression of MDM2 in acute childhood lymhpoblastic leukemia
18. Cellular expression of MDM2 and p53 childhood eukemias with poor prognosis
19. P53 mutations are associated with resistance to chemotherapy and short survival in hematological malignancies
20. The p53 gene in pediatric therapy-related leukemia and myelodysplasia
21. Overexpression of the MDM2 gene by childhood ALL cells expressing the wild type p53 gene
22. A high frequency of sequence alterations is due to formalin fixation of archival speciemen
23. P53, p21, Rb and mdm2 oncoproteins: Expression in normal placenta, partial and complete mole and choriocarcinoma
24. MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue: Comparative studies with p53 expression